Searched for
CAGRISEMA TRIAL UNDERPERFORMANCE
US Stocks | Wall Street ends sharply lower amid AI displacement fears and revived tariff angst- S&P 500, Dow Jones, Nasdaq crash at U.S Stock Market. Top gaining, losing stocks at Wall Street
- Why did NVO stock crash over 14% today? Novo Nordisk’s weight-loss drug CagriSema misses trial goal against Eli Lilly’s Tirzepatide
- Novo Nordisk's $475-billion rise and fall as Wegovy-era gains wiped outNovo Nordisk shares have fallen sharply. Their new obesity drug, CagriSema, did not meet expectations in trials. This setback affects futur...23 Feb, 2026, 10.41 PM IST
Load More